ABVC BioPharma, Inc. Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements
ABVC BioPharma, Inc. (ABVC) reported Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements of 297.00 thousand shares for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements · last filed 2021-11-15
- ABVC BioPharma, Inc. incremental common shares attributable to dilutive effect of equity unit purchase agreements for the quarter ending 2021-03-31 was 132.00K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 9 month |
|---|---|---|---|
| 2021-09-30 | 297.00K shares 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | 197.00K shares 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | 132.00K shares 10-Q · filed 2021-05-10 |